In Vitro 독성 시험 시장 : 유형별, 최종사용자별, 지역별

In Vitro Toxicity Testing Market is estimated to be valued at USD 10.04 Bn in 2025 and is expected to reach USD 24.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

The research activities are conducted to find alternatives to conventional animal-based toxicity testing such as in vitro toxicology assays thatare complemented by in silico and in chemico testing procedures. The metabolic, toxicokinetic, and bioanalytical research is supported by the in vitro toxicity testing services. The establishment of tools for in vitro toxicity assessment, which offers test systems and data required for the development of computer modelling tools for topics like system biology and physiologically based modelling, is a crucial part of this aim. A human cell and organoid-based in vitro technique is becoming increasingly popular for chemical toxicity assessment for a variety of factors including scientific relevance, effectiveness, affordability, and moral propriety.

Market Dynamics

Major players in the market are focused on the research and development activities, and thu,s it is expected to drive the market growth in near future. For instance, on June 21, 2021, a revised test guideline for the fish cell line acute toxicity assay was approved at the 33rd Meeting of the OECD Working Group of the National Coordinators, Austria for the Test Guidelines Programme in April 2021, and it had been published by the International Council on Animal Protection in OECD Programmes (ICAPO). Numerous studies have demonstrated how effectively the assay can forecast acute toxicity to fish for a wide range of chemicals when carried out in compliance with OECD test guidelines. Therefore, by including this assay into a weight of evidence or integrated approach to testing and assessment (IATA) for acute fish toxicity assessment, it has the potential to replace acute fish toxicity testing in a significant way.

Key features of the study

• This report provides an in-depth analysis of the global in vitro toxicity testing market, and provides market size and compound annual growth rate for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global in vitro toxicity testing market based on the following parameters,company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Societe Generale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global in vitro toxicity testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vitro toxicity testing market

Market Segmentation

• Global In Vitro Toxicity Testing Market, By Type
  • Absorption
  • Toxic Substances
  • Dose
• Global In Vitro Toxicity Testing Market, By End User
  • Cosmetics Industry
  • Pharmaceutical Industry
  • Food Industry
  • Chemicals Industry
• Global In Vitro Toxicity Testing Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Global In Vitro Toxicity Testing Market - Key Players
  • Bio-Rad Laboratories, Inc.
  • Cyprotex
  • Covance Inc.
  • LifeNet Health LifeSciences
  • Creative Bioarray
  • Charles River Laboratories
  • Intertek Group plc
  • LGC Limited
  • SGS Societe Generale de Surveillance SA
  • Preferred Cell Systems
  • Microbac Laboratories, Inc.
  • Eurofins Discovery
  • Creative Biolabs
  • LAUS GmbH
  • Vimta Labs Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global In Vitro Toxicity Testing Market, By Type, 2020-2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Absorption
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toxic Substances
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dose
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global In Vitro Toxicity Testing Market, By End User, 2020-2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Cosmetics Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceutical Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Food Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chemicals Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global In Vitro Toxicity Testing Market, By Region, 2020-2032, (USD Bn)

• Overview
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User,2020- 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country ,2020- 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cyprotex
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Covance Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LifeNet Health LifeSciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Bioarray
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Intertek Group plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LGC Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SGS Societe Generale de Surveillance SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Preferred Cell Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Microbac Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eurofins Discovery
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LAUS GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vimta Labs Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us